Oral GLP-1 (Wegovy) Is Here: Dosing, Switching, and What to Expect

About this episode

Spencer and Dr. Karl discuss the introduction of oral GLP-1 Wegovy, its dosing, switching from injections, and insights from SURMOUNT 4 data.

Oral GLP 1 Wegovy is finally here, so Spencer and Dr. Karl break down how it actually works, how to dose it, and how they are switching people from injections like Wegovy and Zepbound in real clinic settings. They also walk through new SURMOUNT 4 data on what happens when people stop tirzepatide, including who maintains, who regains, and why a personalized plan matters.

People in this episode

Host: Spencer

Guest: Dr. Karl

Topics covered

• GLP-1
• Wegovy
• dosing
• switching medications
• SURMOUNT 4 data
• personalized plans

Keywords

• Wegovy
• GLP-1
• dosing
• tirzepatide
• SURMOUNT 4
• weight loss
• medication switching

Mentioned in this episode

Products: Wegovy, Zepbound, tirzepatide

More episodes of Docs Who Lift

• Retatrutide Phase 3 Results: What the Data Actually Means · June 8, 2026 · 45 min
• GLP-1 Maintenance: What Happens When You Lower Your Dose, Switch Medications, or Stop Entirely · May 25, 2026 · 40 min
• Are GLP-1 Medicines Shredding Your Bones? Here Is What the Actual Evidence Says With Dr. Susan Brian · May 18, 2026 · 32 min
• Heavy Metal Toxicity: Separating Real Risks From Influencer Scams | Dr. Eryn Russo · May 5, 2026 · 53 min
• GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton · April 21, 2026 · 25 min
• Do GLP-1 Medicines Actually Cause Muscle Loss? New Research With Dr. Henning Langer · April 14, 2026 · 36 min